SMSPHARMA is looking strong and forming a bullish structure. A breakout from the current level can lead to a good upside move.
Even while paper trading, always use a stop-loss, it builds the right trading habit.
Keep this stock on your watchlist.
✅ If you like my analysis, please follow me here as a token of appreciation :)
in.tradingview.com/u/SatpalS/
📌 For learning and educational purposes only, not a recommendation. Please consult your financial advisor before investing.
Even while paper trading, always use a stop-loss, it builds the right trading habit.
Keep this stock on your watchlist.
✅ If you like my analysis, please follow me here as a token of appreciation :)
in.tradingview.com/u/SatpalS/
📌 For learning and educational purposes only, not a recommendation. Please consult your financial advisor before investing.
Note
SMSPHARMA hasn’t triggered the entry yet and is still moving within a defined range, so updating the levels accordingly.Based on the current structure, an entry around 290 with a 6.8% SL below offers a favourable probability setup.
The upside target remains the same, with the recent swing high near 329 acting as the first probable resistance zone.
📌 For learning and educational purposes only, not a recommendation. Please consult your financial advisor before investing.
Note
SMSPHARMA touched 320 today, gave a massive 10% upside move.Note
SMSPHARMA touched 335 on 27nov, gave a massive 15% upside move.Note
SMSPHARMA touched a high of 341 today, which is equivalent to 18% upside move.Note
SMS PHARMA has achieved its target, delivering a 59-point upside move, equivalent to 20%.While there may still be scope for further upside, it’s important to protect the gains already made. Using a trailing stop-loss strategy helps safeguard profits, as the market can change direction at any time.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
